Akcea Therapeutics Inc (AKCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2016 | 06-2016 | 12-2015 | 12-2014 | |
| Operating Expenses | 19,902 | 13,706 | 0 | 0 |
| Operating Income | -19,902 | -13,706 | N/A | N/A |
| Other Income | 93 | 91 | 0 | 0 |
| Pre-tax Income | -19,809 | -13,615 | 0 | 0 |
| Net Income Continuous | -19,809 | -13,615 | N/A | N/A |
| Net Income | $-19,809 | $-13,615 | $N/A | $N/A |
| EBITDA(a) | $-19,810 | $-13,706 | $N/A | $N/A |